Phototrop^® References
 

1. Feher J, Kovacs B, Kovacs I, Schveoller M, Papale A, Balacco-Gabrieli C. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica 2005;219(3):154-66.
    

2. Feher J, Papale A, Mannino G, Gualdi L, Balacco-Gabrieli C. Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study. Ophthalmologica 2003;217(5):351-7.
    

3. Rotstein NP, Politi LE, German OL, Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003; 44(5):2252-9. 
    

4. Desmettre T, Lecerf JM, Souied EH. Nutrition and age-related macular degeneration. J Franc Opthalmol 2004;27(9 Pt 2):3S38-56.
    

5. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005;24(1):87-138. 
    

6. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 2004;137(4):704-18.
    

7. Bazan NG. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of  docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989;312:95-112.
    

8. Elner VM. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc 2002;100:301-38. 
    

9. Brown NA. Bron AJ. Harding JJ. Dewar HM. Nutrition supplements and the eye.  Eye 1998;12(Pt 1):127-33.